Dashboard
Manage Tickers

STRO


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

overseas-shipholding-micron-squarespace-incyte-and-other-big-stocks-moving-higher-on-monday
Overseas Shipholding, Micron, Squarespace,...
05/20/2024 15:37:53

oppenheimer-maintains-outperform-on-sutro-biopharma-maintains-10-price-target
Oppenheimer Maintains Outperform on Sutro ...
05/15/2024 15:36:34

Oppenheimer analyst Jay Olson maintains Sutro Biopharma (NASDAQ:STRO) with a Outperform and maintains $10 price target.

wedbush-reiterates-outperform-on-sutro-biopharma-maintains-8-price-target
Wedbush Reiterates Outperform on Sutro Bio...
05/14/2024 12:31:01

Wedbush analyst David Nierengarten reiterates Sutro Biopharma (NASDAQ:STRO) with a Outperform and maintains $8 price target.

hc-wainwright--co-reiterates-buy-on-sutro-biopharma-maintains-12-price-target
HC Wainwright & Co. Reiterates Buy on Sutr...
05/14/2024 11:18:47

HC Wainwright & Co. analyst Andrew Fein reiterates Sutro Biopharma (NASDAQ:STRO) with a Buy and maintains $12 price target.

sutro-biopharma-q1-2024-adj-eps-095-misses-092-estimate-sales-13008m-beat-12071m-estimate
Sutro Biopharma Q1 2024 Adj EPS $(0.95) Mi...
05/13/2024 20:41:00

Sutro Biopharma (NASDAQ:STRO) reported quarterly losses of $(0.95) per share which missed the analyst consensus estimate of $(0...

expert-outlook-sutro-biopharma-through-the-eyes-of-10-analysts
Expert Outlook: Sutro Biopharma Through Th...
05/08/2024 13:00:36

b-of-a-securities-initiates-coverage-on-sutro-biopharma-with-buy-rating-announces-price-target-of-12
B of A Securities Initiates Coverage On Su...
05/08/2024 10:16:16

B of A Securities analyst Tazeen Ahmad initiates coverage on Sutro Biopharma (NASDAQ:STRO) with a Buy rating and announces P...

sutro-biopharma-announces-initiation-of-randomized-portion-part-2-of-refrme-o1-trial
Sutro Biopharma Announces Initiation Of Ra...
04/30/2024 12:21:25

piper-sandler-reiterates-overweight-on-sutro-biopharma-lowers-price-target-to-11
Piper Sandler Reiterates Overweight on Sut...
04/03/2024 15:35:21

Piper Sandler analyst Edward Tenthoff reiterates Sutro Biopharma (NASDAQ:STRO) with a Overweight and lowers the price target...

oppenheimer-maintains-outperform-on-sutro-biopharma-maintains-10-price-target
Oppenheimer Maintains Outperform on Sutro ...
04/03/2024 14:06:22

Oppenheimer analyst Jay Olson maintains Sutro Biopharma (NASDAQ:STRO) with a Outperform and maintains $10 price target.

truist-securities-maintains-buy-on-sutro-biopharma-lowers-price-target-to-18
Truist Securities Maintains Buy on Sutro B...
04/03/2024 13:32:45

Truist Securities analyst Asthika Goonewardene maintains Sutro Biopharma (NASDAQ:STRO) with a Buy and lowers the price targe...

jmp-securities-reiterates-market-outperform-on-sutro-biopharma-maintains-17-price-target
JMP Securities Reiterates Market Outperfor...
04/03/2024 12:23:38

JMP Securities analyst Reni Benjamin reiterates Sutro Biopharma (NASDAQ:STRO) with a Market Outperform and maintains $17 pri...

whats-going-on-with-sutro-biopharma-stro-stock
What's Going On With Sutro Biopharma (STRO...
04/02/2024 16:46:17

Sutro Biopharma shares are trading lower by 4.3% during Tuesday's session. The company announced the pricing of an underwri...

sutro-biopharma-priced-an-underwritten-offering-of-1448m-shares-at-518share-with-gross-proceeds-of-approximately-75m
Sutro Biopharma Priced An Underwritten Off...
04/02/2024 10:22:12

Core News & Articles
Ipsen And Sutro Biopharma Enter Exclusive ...
04/02/2024 05:49:31

Ipsen secures exclusive global rights for development and commercialization of STRO-003, an antibody-drug conjugate, completi...

why-kodiak-sciences-shares-are-trading-lower-by-around-20-here-are-other-stocks-moving-in-thursdays-mid-day-session
Why Kodiak Sciences Shares Are Trading Low...
03/28/2024 18:08:52

Shares of Kodiak Sciences Inc. (NASDAQ: KOD) fell sharply during Thursday’s session after the company reported a wider-than-e...

rex-american-resources-reports-upbeat-earnings-joins-avalo-therapeutics-rh-and-other-big-stocks-moving-higher-on-thursday
REX American Resources Reports Upbeat Earn...
03/28/2024 15:00:16

U.S. stocks were slightly higher, with the S&P 500 gaining around 0.1% on Thursday. Shares of REX American Resources Corpo...

oppenheimer-maintains-outperform-on-sutro-biopharma-maintains-10-price-target
Oppenheimer Maintains Outperform on Sutro ...
03/28/2024 11:43:17

Oppenheimer analyst Jay Olson maintains Sutro Biopharma (NASDAQ:STRO) with a Outperform and maintains $10 price target.

navigating-4-analyst-ratings-for-sutro-biopharma
Navigating 4 Analyst Ratings For Sutro Bio...
03/27/2024 12:01:50

oppenheimer-maintains-outperform-on-sutro-biopharma-maintains-10-price-target
Oppenheimer Maintains Outperform on Sutro ...
03/27/2024 11:41:27

Oppenheimer analyst Jay Olson maintains Sutro Biopharma (NASDAQ:STRO) with a Outperform and maintains $10 price target.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION